The Rights of Children and Parents in Regard to Children Receiving Psychiatric Diagnoses and Drugs - Peter R. Breggin. Center for the Study of Empathic Therapy, Private Practice of Psychiatry, Ithaca, New York, USA. CHILDREN & SOCIETY, VOLUME 28, (2014) pp. 231-241.
Psychotherapy in Emotional Crises without Resort to Psychiatric Medications - Peter R. Breggin, Center for the Study of Psychiatry and Psychology. The Humanistic Psychologist, 1997, Vol. 25, No. 1, 2-14.
Brain Damage, Dementia and Persistent Cognitive Dysfunction Associated With Neuroleptic Drugs - Evidence, Etiology, Implications. Peter R. Breggin, Center for the Study of Psychiatry and George Mason University. The Journal of Mind and Behavior, Summer and Autumn 1990, Volume 11, Numbers 3 and 4, Pages 425 [179] - 464 [218].
Psychostimulants in the Treatment of Children Diagnosed with ADHD - Risks and Mechanism of Action. Peter R. Breggin, Director, International Center for the Study of Psychiatry and Psychology (ICSPP). International Journal of Risk and Safety in Medicine 12 (1999) 3-35.
Suicidality, Violence and Mania Caused by Selective Serotonin Reuptake Inhibitors (SSRIs) - A Review and Analysis. Peter R. Breggin. International Journal of Risk and Safety in Medicine 16 (2003/2004) 31-49.
Iatrogenic Helplessness in Authoritarian Psychiatry - Peter R. Breggin, from The Iatrogenics Handbook. Robert Horgan, editor. IPI Publishing, Toronto, Canada, 1983.
Parallels between Neuroleptic Effects and Lethargic Encephalitis - The Production of Dyskinesias and Cognitive Disorders. Peter R. Breggin, Center for the Study of Psychiatry and George Mason University. Brain and Cognition 23, 8-27 (1993).
Psychopharmacology and Human Values - Peter R. Breggin. Journal of Humanistic Psychology, 2003 43:34. jhp.sagepub.com/content/43/2/34.
Recent Regulatory Changes in Antidepressant Labels - Implications of Activation (Stimulation) for Clinical Practice. Written by Peter R. Breggin, MD. Primary Psychiatry; January 2006; 13(1):57-60.
Intoxication Anosognosia - The Spellbinding Effect of Psychiatric Drugs. Peter R. Breggin, MD. Ethical Human Psychology and Psychiatry, Volume 8, Number 3, Fall/Winter 2006.
Court Filing Makes Public My Previously Suppressed Analysis of Paxil's Effects - Peter R. Breggin, MD. Special Report. Ethical Human Psychology and Psychiatry, Volume 8, Number 1, Spring 2006.
How GlaxoSmithKline Suppressed Data on Paxil-Induced Akathisia - Implications for Suicidality and Violence. Special Report, Part II. Written by Peter R. Breggin, MD. Ethical Human Psychology and Psychiatry, Volume 8, Number 2, Summer 2006.
Drug Company Suppressed Data on Paroxetine-Induced Stimulation - Implications for Violence and Suicide. Special Report, Part III. Written by Peter R. Breggin, MD. Ithaca, NY. Ethical Human Psychology and Psychiatry, Volume 8, Number 3, Fall 2006.
Lilly Withheld Documents - An Examination of Eli Lilly and Company's Contentions that the BMJ Prozac Documents were Never Missing and Have no Significance. A report by Peter R. Breggin. January 12, 2005.